drug
sofpironium bromide
Marketedupdated 5mo agoby Botanix Pharmaceuticals Ltd
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying sofpironium bromide
- phase3Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)
- phase3Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
- phase3A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 13, 2026
43 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (20)
- May 22, 2040compositionUS 11566000
- May 22, 2040compositionUS 11584715
- Jul 20, 2037formulationUS 11123325
- May 22, 2034method-of-use (U-2398)US 10947192
- May 22, 2034method-of-use (U-2398)US 10952990
- May 22, 2034method-of-use (U-2398)US 10959983
- May 22, 2034method-of-use (U-2398)US 10961191
- May 22, 2034formulationUS 11026919
- May 22, 2034formulationUS 11034652
- May 22, 2034formulationUS 11052067
- May 22, 2034formulationUS 11084788
- May 22, 2034formulationUS 12156865
- May 22, 2034formulationUS 12357609
- May 22, 2034formulationUS 12398102
- Mar 14, 2034method-of-use (U-2398)US 10383846
- Mar 14, 2034method-of-use (U-2398)US 9220707
- Mar 14, 2034formulationUS 9492429
- Mar 14, 2034method-of-use (U-2398)US 9895350
- Mar 26, 2027compositionUS 8147809176d
- Nov 13, 2026method-of-use (U-2398)US 862875943d
FDA exclusivities (1)
- Jun 20, 2029NCENew Chemical Entity (5y)2.7y
News(1)
- 4 CDMOs to consider when outsourcing manufacturingContract development and manufacturing organizations looking to do business with biopharmas include Lonza, which has more than 30 sites, and Samsung Biologics, which recently announced a planned ac…biospace · 23d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that